The role of the helper lipid dioleoylphosphatidylethanolamine (DOPE) for DNA transfection cooperating with a cationic lipid bearing ethylenediamine  by Mochizuki, Shinichi et al.
Biochimica et Biophysica Acta 1828 (2013) 412–418
Contents lists available at SciVerse ScienceDirect
Biochimica et Biophysica Acta
j ourna l homepage: www.e lsev ie r .com/ locate /bbamemThe role of the helper lipid dioleoylphosphatidylethanolamine (DOPE) for DNA
transfection cooperating with a cationic lipid bearing ethylenediamine
Shinichi Mochizuki a, Naho Kanegae a, Koichi Nishina a, Yumi Kamikawa a, Kazunori Koiwai b,
Hiroyasu Masunaga c, Kazuo Sakurai a,d,⁎
a Department of Chemistry and Biochemistry, The University of Kitakyushu, 1–1, Hibikino, Wakamatsu-ku, Kitakyushu, Fukuoka 808–0135, Japan
b Terumo Corporation R & D Center, 1500 Inokuchi, Nakai-machi, Ashigarakami-gun Kanagawa 259–0151, Japan
c Japan Synchrotron Radiation Research Institute (JASRI/SPring-8), 1-1-1 Kouto, Sayo, Hyogo 679–5198, Japan
d CREST, Japan Science and Technology Agency, 4-1-8, Honcho, Kawaguchi-shi, Saitama 332–0012, Japan⁎ Corresponding author at: Department of Chemistry an
of Kitakyushu, 1–1, Hibikino, Wakamatsu-ku, Kitakyus
Tel.: +81 93 695 3298; fax: +81 93 695 3390.
E-mail address: sakurai@kitakyu-u.ac.jp (K. Sakurai)
0005-2736/$ – see front matter © 2012 Elsevier B.V. Al
http://dx.doi.org/10.1016/j.bbamem.2012.10.017a b s t r a c ta r t i c l e i n f oArticle history:
Received 11 July 2012
Received in revised form 28 August 2012
Accepted 16 October 2012
Available online 23 October 2012
Keywords:
Lipoplex
DOPE
pH responsiveness
Structural transitionGene therapy is expected to treat various incurable diseases including viral infections, autoimmune disorders,
and cancers. Cationic lipids (CL) have been used as carriers of therapeutic DNAs for gene therapy because
they can form a complex with DNA and such a complex can be incorporated into cells and transport the bound
DNA to cytosol. The CL/DNA complexes are called lipoplexes and categorized as a non-viral vector. Lipoplexes
are often prepared by adding a neutral phospholipid dioleoylphosphatidylethanolamine (DOPE) to CL in order
to enhance transfection. However, the role of DOPE is not fully understood. We synthesized a new CL having an
ethylenediamine cationic head group, denoted by DA, and found that addition of DOPE to DA achieved a good
efﬁciency, almost in the similar level of commonly used transfection reagent Lipofectamine 2000 (Invitrogen).
The composition of DA:DOPE=1:1 showed the highest efﬁciency. This lipoplex showed structural transition
when pHwas changed from 7 to 4, corresponding pH lowering in late endosome,while DOPE itself showed struc-
tural transition at more basic pH around 8. The present data showed that the DOPE/DA composition determines
the structural transition pH and choosing a suitable pH, i.e., a suitable composition, is essential to increase the
transfection efﬁciency.
© 2012 Elsevier B.V. All rights reserved.1. Introduction
Nucleic acid-based therapeutic by plasmid DNA is able to cure vari-
ous incurable diseases including viral infections, autoimmune disorders,
and cancers [1,2]. It is considered that there are two major barriers to
deliver these molecules to achieve the maximum effect: the ﬁrst one
is cellular uptake and the second is endosomal escape [3]. A number
of approaches to overcome these barriers have been investigated in-
cluding liposomes and cationic polymers. Since cationic lipids are one
of the most powerful tools for plasmid DNA gene transfection, several
types of transfection reagents are proposed and some of them are com-
mercially available now. Supramolecular complexes made from pDNA
and synthetic cationic lipids are called lipoplexes and expected as a can-
didate to alternate viral vectors [4–6]. Viral vectors such as retrovirus
and lentivirus are prepared by genetically modifying a highly infectious
natural virus and their safety issues have been concerned in terms ofd Biochemistry, The University
hu, Fukuoka 808–0135, Japan.
.
l rights reserved.immunity [7] as well as possibility of oncogenicity [8]. Lipoplex exhibits
low toxicity, nonimmunogenicity and easy to preparation, but their
mechanism of expression still remains unknown. As the most critical
issue, its transfection efﬁciency has to be drastically increased to match
practical use.
Saﬁnya et al. are the ﬁrst to advocate the relation between the su-
pramolecular structures of lipoplexes and their transfection efﬁciency
by use of synchrotron small angle X-ray scattering (SAXS) [5,9–13].
According to them, the inverted hexagonal structure with DNA encap-
sulated within cationic lipid monolayers tubes is more suitable for the
transfection [5,13]. Their extensive work presented a hypothesis that
there is some speciﬁc structure in lipoplexes to induce fusion with cel-
lularmembranes and thus increase the transfection efﬁciency. This idea
is supported by Koynova et al. with different lipoplex systems [14–17].
It is considered that one of the pathway for lipoplexes to enter the
cell is endocytosis [18]. To fulﬁll the function of pDNA, it has to escape
from endosomal compartments. In recent researches, the various types
of cationic lipids that induce structural transitions as pH change from 6
to less than 5 are synthesized and they showed good transfection efﬁ-
ciency [19,20]. These studies showed that the pH-dependent structural
transition is relevant to the transfection efﬁciency. This is because that
the pH inside of cellular transport vesicles decreases to less than 5 in
Table 1
Molar ratio of co-lipids.
Sample no. DA DOPE DOPE/(DA+DOPE)
No. 0 1 0 0.000
No. 1 7 1 0.125
No. 2 3 1 0.250
No. 3 5 3 0.375
No. 4 1 1 0.500
No. 5 1 2 0.666
No. 6 1 3 0.750
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sion between the lipoplex and the vesicle bilayer to release the bound
DNA. The similarmechanism is proposed for the polycation/DNA systems
called “proton sponge” effect [21]. Referring the previous studies, it seems
that this pH responsiveness is themajor factor to increase the transfection
[22].
To increase transfection activity, a neutral phospholipid
dioleoylphosphatidylethanolamine (DOPE, see Fig. 1a for the chemi-
cal structure) is added to cationic lipids as a helper co-lipid [4,23–25].
DOPE is a phospholipid which is known to exhibit structural transition
with pH change. DOPE takes a spherical micelle above pH 9.0 and this
morphology can transform to an inverted hexagonal (HII) one at
acidic pH [26,27]. Although this transition is believed to be relevant
to endosomal release of DNA by accelerating the fusion [13,28], there
seems no concrete evidence to support this mechanism.
We have reported that the lipid having an aromatic liker connected
with ethylene diamine (DA) can beused as a transfection reagentwith a
better efﬁciency and less cytotoxicity by combining with DOPE and
dilauroyl phosphatidylcholine (DLPC) than the conventional reagents
or other lipidswith benzyl amine or amidine[29]. In this study, a cation-
ic lipid bearing a DA at head groupwas synthesized and the relationship
between the structural transition of lipoplexes by pH change and the
transfection efﬁciency was examined as the function of the DOPE and
the cationic lipid composition.2. Materials and methods
2.1. Synthesis of the cationic lipid DA
Synthesis of N-(3,5-dialkylbenzyl) ethane-1,2-diamine (DA, see
Fig. 1b) was performed as described in our previous report [30]. The
obtained DA was identiﬁed by 1H NMR. δH (500 MHz, CDCl3) 6.47
(2H, s, ArH), 5.30 (1H, br s, NH), 3.88 (4H, t, J=6.5 Hz, 2×OCH2 and
2H, s, CH2CH2NH2), 3.14 (2H, s, NHCH2CH2), 3.05 (2H, s, CH2NH2), 1.73
(4H, q, J=9.3 Hz, 2×OCH2CH2), 1.42–1.39 (4H, m, 2×OCH2CH2CH2),
1.29–1.25 (32H, m, 2×C13H27), 0.88 (6H, t, J=7.0 Hz, 2×CH3).2.2. Preparation of the DA/DOPE lipoplexes
WemixedDA andDOPE (Wako Pure Chemical Industries, Ltd., Osaka,
Japan) at various compositions as shown in Table 1 and dissolved them
in chloroform and vacuum dried. Each mixture was dissolved in 3 mM
phosphate buffer (pH 7.4) and the plasmid DNA (pDNA) encoding lucif-
erase (pGL3-Control Vector; Promega,Madison,WI)was added at differ-
ent cation/anion charge ratio ([cationic amino groups]cationic lipid/[anionic
phosphate group]nucleic acid; N/P)=6, unless stated otherwise. To con-
ﬁrm the complexations, the mixtures were separated by 1% agarose gel
electrophoresis. DNA was stained with ethidium bromide (10 ng/ml)
and the image was obtained using a PharosFX (Bio-Rad, Richmond, CA).H3N O P
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Fig. 1. Chemical structure of DOPE (a) and DA (b).2.3. Gene transfection
HepG2 cells were seeded at 1.0×104 cells in a collagen-coated
96-well microplate and incubated at 37 °C under 5% CO2. The cells
were cultured in DMEM containing 10% FBS and 100 U/ml penicillin,
and 0.1 mg/ml streptomycin. After 24 h, the cells were transfected
with the pDNA at 0.2 μg/ml using the lipoplex or the Lipofectamine
2000 (Invitrogen, Carlsbad, CA) according to the manufacturer's in-
struction. In brief, on the day of transfection, the medium was re-
moved and replaced with fresh medium with or without serum.
DA/pDNA and Lipofectamine 2000/pDNA complexes were added
into the serum containing and free wells, respectively. After 6 h,
the dish transfected with Lipofectamine 2000 was replaced with
fresh medium containing serum. After 48 h, the cells were washed
with PBS twice adequately and then lysed with a lysis buffer from
the luciferase assay kit (Promega). The luciferase activity in a 10 μL
aliquot of the cell lysate wasmeasured with a luminescence plate reader
(Wallac 1420; Perkin Elmer, Wellesley, MA). The protein concentration
of eachwell lysatewas determined by a standard protein assay (Dojindo,
Kumamoto, Japan). The luciferase activity in each sample was normal-
ized to the luminescence intensity per microgram of protein.
2.4. Chronological change of gene expression
HepG2 cells were seeded at 2.0×105 cells in 35-mm dishes and
incubated for 24 h. After washingwith DMEM, the cells were transfected
with pDNAat 2 μg/ml using the lipoplex or the Lipofectamine 2000 under
serum containing and free circumstances, respectively. After 6 h, theme-
dium was removed and replaced with fresh medium containing serum
and the luciferin at 10 μM. The luminescence in the dish was chronolog-
ically measured with Kronos Dio (ATTO Co., Tokyo, Japan).
2.5. Cytotoxicity of the lipoplexes
The cytotoxicity of the lipoplexes made from the cationic lipids
and pDNA was investigated with HepG2 cells. The cells were seeded
at 1.0×104 cells in a collagen-coated 96-well microplate and incubated
at 37 °C under 5% CO2 for 24 h. Themedium in the cell culture platewas
changed to a fresh medium (100 μl) containing an appropriate concen-
tration of the lipoplexes diluted with a medium containing 10% FBS.
After incubation at 37 °C for 24 h, the mediumwas changed to a me-
dium (110 μl) containing a tetrazolium salt (WST-1; Dojindo) and
incubated for 2 h. Formazan is then produced by succinate-tetrazolium
reductase in living cells. The absorbance at 450 nm was monitored
using a microplate reader (Maltiskan JX; Thermo SCIENTIFIC, Waltham,
MA) [31].
2.6. Uptake of lipoplexes into the cell
HepG2 cells were seeded at 2.0×105 cells in 35-mm dishes and
incubated for 24 h. After washedwith DMEM, the cells were transfected
with the FITC-labeled pDNA at 2 μg/ml in serum for Lipofectamine 2000
and without serum for DA/DOPE, respectively. Six hours later, the cells
werewashedwith PBS twice and collected and theﬂuorescence intensi-
ty of the cells was measured with a ﬂow cytometer (Epics XL; Beckman
414 S. Mochizuki et al. / Biochimica et Biophysica Acta 1828 (2013) 412–418Coulter, Fullerton, CA). FITC-labeled pDNAwas prepared using Label IT®
Fluorescein Labeling Kit (Mirus Bio LLC., Madison, WI).
2.7. Small angle X-ray scattering (SAXS) measurement
The lipoplexes solutions (N/P=6) or dispersedDOPE solutionswere
adjusted its pH by adding 0.1 N NaOH and 0.1 N HCl and measured the
pH dependency of the structure with SAXS. SAXS measurements were
carried out at 40B2 SPring-8 with a 700 mm camera using a Rigaku
imaging plate (30×30 cm, 3000×3000 pixels) as a detector. Thewave-
length of the beam was 0.71 Å, and the exposure time was 2 min.
2.8. Vulnerability assay of the DA/DOPE lipoplexes in the late endosome
As an analogue of endosomal compartment, anionic micelles were
made from phosphatidylserine (critical micelle concentration; 50 μM,
Wako, denoted by PS) according to Zelphati's method [32]. PS was
dissolved in chloroform at 1.6 mM and then vacuum dried. Phosphate
buffer (3 mM) was added to the dried sample and a dispersed solution
was obtained with ultra-sonication. We mixed the PS micelle and the
lipoplexes at amolar ratio of 1:5 for DA+DOPE:PS. The ﬁnal concentra-
tion of PS was always ﬁxed at 0.2 mM. After incubated the mixtures for
1 h at pH 5 or 7, the amount of the release of pDNA from the lipoplexes
was examined with agarose gel electrophoresis.Time (h)
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Fig. 2. Conﬁrmation of the complexes made from DA-DOPE lipids and pDNA at N/P ratio=6
Data represent the mean±S.D. of triplicate wells (b). Chronological changes of the protein e
and Lipofectamine 2000 (N/P=6). Data represent the mean±S.D. of triplicate wells (d).3. Results
3.1. Gene expression efﬁciency
After mixed pDNA with DA/DOPE at N/P=6, at this N/P the trans-
fection reached the maximum for the DOPE/DLPC system [29], DNA
binding was examined with agarose gel electrophoresis (Fig. 2a).
There were no free DNA bands observed for No. 0–No. 3, while the
amount of free DNA was increased from No. 4 to No. 6 (i.e., with in-
crease of DOPE), indicating that excess DOPE diminishes the com-
plexation yield between DA and pDNA. Gene expression was
examined for each lipoplex (Fig. 2b). DA lipid alone (No. 0) hardly in-
duced the expression, even though it has a cationic head. The expres-
sion was increased by adding DOPE and reached the maximum at
No. 4. It should be noted that the expression level for No. 4 was larger
than Lipofectamine 2000. Fig. 2c shows the chronological changes of
the luminescence intensity after transfection. The intensities in-
creased sigmoidally, reached a plateau at 40–50 h, and gradually de-
creased for all samples, indicating that all of them needed a similar
induction period to reach the maximum in express protein. This can
be interpreted that all lipoplexes take the same pathway for all the
way from cellular uptake to nucleo-internalization. Cell viability was
examined 24 h after transfection (Fig. 2d). DA itself showed no cyto-
toxicity. The lipoplexes containing DOPE showed toxicity. No. 1 and
No. 2 showed a relatively larger cytotoxicity than the others and the0
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(a). Transfection efﬁciencies for the lipoplexes with various content of DOPE (N/P=6).
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Fig. 4. Chemical structure of DOTAP (a). Transfection efﬁciencies for the DOTAP-DOPE
lipoplexes with various content of DOPE (N/P=6). Data represent the mean±S.D. of
triplicate wells (b).
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crease of DOPE. This result can be interpreted by that once DA is
ingested in the cells, it becomes toxic while DOPE is not as toxic as
DA. For No. 4, we examined N/P ratio dependence of the expression,
after conﬁrming that pDNA was completely complexed at N/P>2
(Fig. 3a). The expressions showed the almost same levels at N/P=2
and 4, equivalent to Lipofectamine 2000 (Fig. 3b). At N/P=10, the cy-
totoxicity was increased and it seemingly depressed the expression.
As the optimum compositions, we chose DA/DOPE=1 (No. 4) at
N/P=2–6.
The gene expression was examined for another cationic lipid
dioleoyltrimethylammoniumpropane (DOTAP; Sigma, Fig. 4a) [33],
which is one of the commonly used and commercially available cat-
ionic lipids and have been used for transfection after mixing with a
neutral lipid such as DOPE or dioleoylphosphatidylcholine (DOPC).
We prepared the lipid mixtures from DOTAP and DOPE at the same
composition with Table 1 instead of using DA. As in the case of DA/
DOPE, DOTAP alone induced a little expression. Similarly to the DA
system, the addition of DOPE increased the expression, while the
maximum composition was different. The optimum composition for
the expression was No. 2 for DOTAP (Fig. 4b), instead of No. 4.
3.2. Uptake of the lipoplexes into the cell
The amounts of ingested FITC-pDNA were compared in Fig. 5. The
number inserted in each panel indicates the percentage of the cells
incorporating DNA. Naked DNA was hardly incorporated into cells.
DA alone showed poor uptake. Addition of DOPE to DA induced uptake,
being consistent with the expression assay. The cellular population in-
corporating DNA was 5–10% for DA/DOPE, while it was about 50% for
Lipofectamine 2000. There was considerable difference between DA/
DOPE and Lipofectamine 2000; however, the gene expression efﬁciency
was almost same. These facts can be understood by presuming that once
DNA is taken up by cells, the survival rate or efﬁciency to reach the ﬁnal
protein expression may be larger in DA/DOPE than in Lipofectamine
2000.
3.3. pH-dependent structural transition of the lipoplexes
We examined pH induced structural transitions for the lipoplexes
using SAXS (Fig. 6). All of the scattering patterns consisted of rather
shape diffraction peaks, indicating that DA/DOPE lipids took ordereda
N/P 0 1 2 4 6 10
Fig. 3. Conﬁrmation of the complexes (a) and transfection efﬁciencies (b) using No.structures after mixed DNA as well as lipids themselves. The exact
structure can be deduced from the relationship between the peak posi-
tions and the Bragg equation. For example, when the peak positions for
the ﬁrst and second ones satisfy the 1:2 relation, the complex takes la-
mellar structures [34] andwhen it is 1:√3:2, it takes hexagonally packed
cylinders [35]. As presented in Fig. 6a, No. 0 took a hexagonally packed
cylinder before adding pDNA and the addition changed to a lamella for
all pH. After adding pDNA, the 1st peak shifted to the lower angle side,
indicating that the distance of the periodic order was increased. The
same lamellar spacing was observed from pH 6.8 to 4.8, indicating that
DA itself does not induce any structural transition upon pH change.
No. 2 also took a hexagonally packed cylinder before adding pDNA at
neutral pH (Fig. 6b). Addition of pDNA did not change the structure atb
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Fig. 5. Uptake of the complexes consisting of each lipid and FITC-labeled pDNA (N/P=6, FITC-pDNA; 2 μg/ml) into HepG2 cells.
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With decreasing pH to less than 6.6, lamellar peaks appeared. It looks
like the peak position was shifted with decreasing pH from 6.6 to 4.8;
the higher pH was d=6.15 nm while the lower one was d=5.90 nm,
where d is the lamellar spacing determined with the Bragg equation.
No. 4 also took a hexagonally packed cylinder without pDNA and
(Fig. 6c). No. 4 lipoplex formed a lamella at pH 7.0 with a spacing of
5.5 nm. The spacing drastically increased and reached to 6.1 nm with
decrease of pH to 4.0. Additionally, the 1st peak became sharper and the
2nd peak became more observable than those in neutral pH. Therefore,a b
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Fig. 6. The structural changes upon pH for No. 0 (a), No. 2 (b) and No. 4 (c) measured wit
proﬁle.these lamellae are considered to have different molecular origin. The
present results indicate that added DOPE can induce pH responsive tran-
sitions and the amount of DOPE determines the transition occurring pH
and the type of structures.
3.4. Interactions between lipoplexes and anionic micelle
To evaluate whether the bound DNA in lipoplexes can be released
upon changing pH in endosomal pathway, we examined the amount
of DNA released from the lipoplexes after mixing with the PSc
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made from PS can a good model for endosomal vesicle [32]. When DNA
release was observed upon pH lowering after mixing with lipoplexes
and PS, we could expect that the same thingmay occur at late endosome.
There was no DNA release observed at any pH for No. 0 and 2. On the
other hand, No. 4 did not release DNA at pH 7 and it clearly released
the half of the complexed DNA at pH 5 (Fig. 7). We conﬁrmed that the
DNA release did not occur without PS. The preset results can be
interpreted by that DOPC is necessary to release DNA in pH responsive
manner and this ability can be related to the structural change due to
pH change. As a control, we examined Lipofectamine 2000 and found
that the release occurred at both pH 5 and pH 7.10-2
100
I
1 5 9
pH 3.7
pH 6.2
q (nm-1) 
Fig. 8. The structural transition induced by pH change for DOPE micelle.4. Discussion
4.1. pH responsive structural transition of DOPE
There are many reports that have been pointed out the importance
of DOPE to signiﬁcantly increase the transfection efﬁciency [17,36]. In
this sense, DOPE is often called a “helper lipid.” The enhanced efﬁciency
due to DOPE has been attributed to the propensity of DOPE to adopt
inverted hexagonal (HII), because the structures are known to play a
critical role in fusion and thus destabilize the endosomal membrane
[23–25]. Recently, it was proposed that DOPE can destabilize the bind-
ing between cationic lipids and DNA, resulting in facilitated release of
DNA from lipoplexes [28,37,38]. Other experimental data suggested
that lowering of the pH in endosomal compartments is not expected
to directly affect the stability of lipoplexes [39,40]. To understand the
molecular origin of the pH dependence of DOPE, we investigated the
pH responsiveness of the micelle made from only DOPE (Fig. 8). At a
high pH of 10.8, a spherical micelle was formed judging from the scat-
tering proﬁle. The peaks of hexagonally packed cylinders appeared
with decrease of pH, indicating that DOPE itself has an ability to induce
structural transition with decreasing pH. The transition took place be-
tween pH=9 and 7, which is consistent with previous reports [27]. It
was known that DOPE is considered to take an inverted hexagonal
phase from its packing parameter analysis [41]. As presented in Fig. 1,
DOPE has a primary amine and a phosphoric acid moiety as a zwitter
type head and they are strongly interacting through water molecules.
At the basic pH, the phosphoric group is negatively charged and thus
creates repulsion between the heads. Upon decreasing pH, hydrogen
bonds or electrostatic attractive forces may form between inter- and
intra-molecular manner, which should be the major reason for the
formation of the hexagonally packed cylinders. Therefore the origin of
the transition of DOPE is to be owing to its zwitter head nature.pH7pH5 pH5pH7pH5pH7pH5
No. 0
++ +++ ++
No. 2 No. 4 No
Fig. 7. DNA release proﬁles measured with gel electrophoresis to examine the interaction b
indicate without and with mixing the phosphatidyl serine micelle.4.2. Molecular mechanism of enhanced transfection due to DOPE
Neither DA nor DOPE has ability to transfect DNA. Only when they
were mixed at a certain composition range around 1:1, the mixture
showed enhanced cellular uptake (Fig. 5) and good protein expression
aswell as low cytotoxicity (Fig. 2).We obtained similar results for anoth-
er cationic lipid DOTAP (Fig. 4). As presented in Fig. 8, when DOPE itself
was examined, the pH that induces the structural transitions of the DOPE
micelles was at 10–9, being far above the cellular milieu. DA alone did
not show structural transitions at any pH (Fig. 6). When DA and DOPE
were mixed, the transition pH was decreased. For the optimal composi-
tion for the transfection, the transition pH was around 4–5. These facts
suggest that the structural transition is correlated to the good transfec-
tion. We can presume that if it occurs inside of the endosomal vesicle
due to the endosome maturing process (i.e., pH lowering), the lipoplex
may interact with the bilayer of the vesicle and thus could cause to re-
lease the bound DNA or to escape into cytosol. This speculation was
supported by the result in Fig. 7, where the DNA release by loweringpH7 pH7pH5 pH7pH5
DNA
PS+ -++ - -
. 6
Lipofectamine
2000 No. 4
etween the lipoplexes and the phosphatidyl serine micelles at pH 7 and 5. PS− and +
418 S. Mochizuki et al. / Biochimica et Biophysica Acta 1828 (2013) 412–418pH was observed for the optimal composition. Therefore, we can con-
clude that the role of DA is tuning the transition pH of DOPE so as to in-
duce interaction in the pH lowering in endocytosis; as a result, the
transfectionwas increased. Other role of DA is to bind the cellular surface
owing to the electrostatic interaction. This is because the cellular surface
is generally charged negatively owing to the presence of phospholipids.
5. Conclusions
When a cationic lipid DA was mixed with DOPE at a certain compo-
sition, it showed the same transfection efﬁcacy as Lipofectamine 2000.
DOPE is responsible for the pH responsive structural transition and the
adding of DA can tune the transition pH well-suited to the pH change
in the endosomal maturing. This role of DOPE can be generalized for
other cationic lipids containing DOPE as a helper lipid.
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